Jupiter Neurosciences faces Nasdaq delisting after market value falls below $35 million threshold - JUNS News | RalliesJupiter Neurosciences faces Nasdaq delisting after market value falls below $35 million threshold
J
JUNS• Company regains minimum bid price compliance
- Separately, the stock regained compliance with Nasdaq’s $1 minimum bid price rule after 10 straight sessions at or above $1.
Nasdaq moves to delist Jupiter Neurosciences common stock
- Nasdaq staff moved to delist Jupiter Neurosciences’ common stock from the Nasdaq Capital Market on Aug. 27, 2026.
- The market value of listed securities stayed below the $35 million minimum under Nasdaq Listing Rule 5550(b)(2) through Aug. 25, 2026.
- The company plans to appeal to the Nasdaq Hearings Panel, which is expected to stay the delisting pending a final decision.
